Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, United States.
Bioconjug Chem. 2020 May 20;31(5):1522-1528. doi: 10.1021/acs.bioconjchem.0c00172. Epub 2020 May 11.
The coming era of precision nanomedicine demands engineered nanoparticles that can be readily translated into the clinic, like that of molecular agents, without being hindered by intrinsic size heterogeneity and long-term body retention. Herein we report that conjugation of indocyanine green (ICG), an FDA-approved near-infrared (NIR) dye, onto an atomically precise glutathione-coated Au25 (GS-Au25) nanocluster led to a molecular-like photothermal nanoparticle (ICG-GS-Au25) with significantly enhanced ICG photostability and tumor targeting. Under weak NIR light irradiation conditions, free ICG failed to suppress tumor growth but the original tumors were completely eradicated with ICG-GS-Au25. In the meantime, "off-target" ICG-GS-Au25 was effectively cleared out from the body like small-molecule drugs after glutathione-mediated biotransformation in the liver. These findings highlight the merits of molecular-like nanomedicines, offering a new pathway to meet FDA's criteria for the clinical translation of nanomedicines.
精准纳米医学的新时代要求能够像分子药物那样,容易转化为临床应用的工程化纳米颗粒,而不会受到固有尺寸异质性和长期体内滞留的阻碍。在此,我们报告称,将 FDA 批准的近红外 (NIR) 染料吲哚菁绿 (ICG) 接枝到原子精确的谷胱甘肽包裹的 Au25(GS-Au25)纳米团簇上,导致具有显著增强的 ICG 光稳定性和肿瘤靶向性的类似分子的光热纳米颗粒 (ICG-GS-Au25)。在弱 NIR 光照射条件下,游离的 ICG 未能抑制肿瘤生长,但用 ICG-GS-Au25 处理后,原始肿瘤完全被消除。同时,在肝脏中谷胱甘肽介导的生物转化后,“非靶向”的 ICG-GS-Au25 像小分子药物一样从体内有效清除。这些发现突出了类似分子的纳米药物的优点,为满足 FDA 对纳米药物临床转化的标准提供了新途径。